Globe Trotting
Siemens Healthineers to acquire Corindus Vascular Robotics for USD 1.1 billion
Siemens Healthineers AG has agreed to acquire Waltham, Massachusetts-based Corindus Vascular Robotics. The all-cash deal has a purchase price of approximately USD 1.1 billion, or USD 4.28 per share. Corindus specializes in precision vascular robotics solutions, such as the FDA-approved CorPath platform for percutaneous coronary and vascular procedures.
“Corindus has established a leading position in vascular robotics with a compelling technology platform for robotic-assisted coronary, peripheral, and neurovascular procedures,” says Michel Therin, president of advanced therapies at Siemens Healthineers. “The acquisition of Corindus, combined with Siemens’ strong advanced therapies portfolio will help further advance the growth of vascular robotics. The integration of our technologies could lead to reduced variability, improved efficiency, expanded access to care, and ultimately improved patient outcomes,” he adds.
Mark J. Toland
President and CEO,
Corindus“We are pleased to have reached this agreement with Siemens Healthineers. We believe the transaction will deliver immediate, compelling, and certain value to all Corindus stockholders, as well as substantial benefits to our customers. The combination of Siemens Healthineers’ advanced, high-quality imaging, digital and artificial intelligence tools with Corindus’ precision robotics platform has the potential to transform the way healthcare is delivered to those suffering from cardiovascular or peripheral disease.”
